Rupesh R. Kotecha MD
Radiation Oncologist, Chief of Radiosurgery, and Director of CNS Metastasis Program, Miami Cancer Institute, Baptist Health South Florida; Associate Professor, FIU Herbert Wertheim College of Medicine, Miami, Florida; Adjunct Faculty at Memorial Sloan Kettering, New York, New YorkRupesh Kotecha, MD, is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is also an Adjunct Faculty at Memorial Sloan Kettering at New York. He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, and GammaKnife radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy. During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and over 75 articles in peer-reviewed journals, including the Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics, Cancer, and Practical Radiation Oncology. His research bandwidth spans investigator initiated trials to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group , coordinates the NCI Glioblastoma Clinical Working Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.
Specialty: Radiation Oncology
Procedures Performed:
- 3-D conformal radiotherapy
- Brachytherapy
- External beam radiotherapy
- Gamma Knife radiosurgery
- Cyberknife radiosurgery
- Image-guided radiation therapy
- Intensity modulated radiation therapy
- Stereotactic body radiotherapy
- Stereotactic ablative radiotherapy
- Re-irradiation
- Spatially fractionated radiotherapy
- MR-guided radiotherapy
- Proton beam radiotherapy
- Cardiac radiosurgery
Education, Fellowship, & Training
Medical School – Michigan State University College of Human Medicine, East Lansing, Mich.
Residency – Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio
Disclosures
Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., and Brainlab and institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay Inc., and Brainlab.
Recent Contributions to PracticeUpdate:
- Impact of Systemic Disease on CNS Disease Control After Stereotactic Radiosurgery to Breast Cancer Brain Metastases
- Radiomics-Based Prediction of Local Control Following Postoperative Stereotactic Radiotherapy in Patients With Brain Metastases
- 18F-Fluciclovine Diagnostic Performance for Recurrent Brain Metastasis
- 2022 Top Story in Brain Cancer: Proton Craniospinal Irradiation for Leptomeningeal Disease
- ESMO 2022: Recommendations From Dr. Rupesh Kotecha for CNS Tumors
- ASCO 2022: Abstract Recommendations From Dr. Rupesh R. Kotecha for Brain Cancer
- The End-of-the-Road for Immunotherapies in GBM or New Opportunities for More Nuanced/aggressive Approaches? CheckMate 498
- Radiotherapy Plus Nivolumab or Temozolomide for Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
- Epidemiology and Risk Factors of Primary CNS Tumors in Children and Adults
- Change in Hippocampal Volume as a Function of Radiation Dose